TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Carls-Bergh Pharma AB
Closing information (x1000 DKK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
14,341
|
14,928
|
18,273 |
Financial expenses |
17
|
32
|
12 |
Earnings before taxes |
-692
|
106
|
2,983 |
EBITDA |
-489
|
398
|
3,229 |
Total assets |
17,531
|
16,688
|
16,474 |
Current assets |
9,900
|
8,960
|
8,207 |
Current liabilities |
4,477
|
2,875
|
2,381 |
Equity capital |
10,934
|
10,835
|
11,716 |
- share capital |
134
![]() |
134
|
145 |
Employees (average) |
12
|
14
![]() |
14 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
62.4%
|
64.9%
|
71.1% |
Turnover per employee |
1,195
|
1,066
|
1,305 |
Profit as a percentage of turnover |
-4.8%
|
0.7%
|
16.3% |
Return on assets (ROA) |
-3.9%
|
0.8%
|
18.2% |
Current ratio |
221.1%
|
311.7%
|
344.7% |
Return on equity (ROE) |
-6.3%
|
1.0%
|
25.5% |
Change turnover |
-664
|
-1,865
|
2,283 |
Change turnover % |
-4%
|
-11%
|
14% |
Chg. No. of employees |
-2
|
0
![]() |
0 |
Chg. No. of employees % |
-14%
|
0%
![]() |
0% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.